Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus

被引:30
作者
Aepfelbacher, FC
Yeon, SB
Weinrauch, LA
D'Elia, J
Burger, AJ
机构
[1] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Noninvas Cardiol Lab, Boston, MA 02215 USA
[2] Mt Auburn Hosp, Boston, MA USA
[3] Joslin Diabet Ctr, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
diabetes mellitus; left ventricular hypertrophy; echocardiography; glycemic control;
D O I
10.1016/j.ijcard.2003.04.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetes mellitus has been associated with abnormalities of cardiac function and left ventricular hypertrophy. We sought to determine whether improved glycemic control in patients with type 1 diabetes mellitus will induce reversal of those abnormalities. Methods: We prospectively studied 19 patients (mean age 40 +/- 9 years) with longstanding type 1 diabetes mellitus (28 +/- 4 years), who participated in a program of stringent glycemic control. Glycemic control was monitored with hemoglobin A1c levels, and improvement was defined as >1% (absolute) decrease of hemoglobin A1c. Two-dimensional and Doppler echocardiograms and ambulatory 24-h blood pressures were obtained at baseline and after 1 year. Left ventricular mass was determined using the area-length method. Results: In the patients with improved glycemic control (n = 12), hemoglobin A1c decreased from 9.8% to 7.8% (p less than or equal to 0.0001), interventricular septal thickness decreased from 10.3 to 9.4 mm (p less than or equal to 0.05), and left ventricular mass regressed from 205 to 182 g (p less than or equal to 0.05). Septal thickness and left ventricular mass remained unchanged in the patients who did not achieve improvement of glycemic control. Left ventricular internal diameters, posterior wall thickness, fractional shortening, E/A ratio of mitral inflow, E-wave deceleration time (DT), and ambulatory 24-h blood pressures did not change significantly after I year in either group. Conclusions: Improved glycemic control in patients with type I diabetes mellitus is associated with regression of septal thickness and left ventricular mass without significant effect on systolic or diastolic function, in the absence of significant alterations in ambulatory 24-h blood pressures. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 25 条
[1]  
ARONSON D, 1998, TXB CARDIOVASCULAR M, P171
[2]   ASYMPTOMATIC DIABETIC CARDIOMYOPATHY - A NONINVASIVE STUDY [J].
ATTALI, JR ;
SACHS, RN ;
VALENSI, P ;
PALSKY, D ;
TELLIER, P ;
VULPILLAT, M ;
LANFRANCHI, J ;
SEBAOUN, J .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1988, 4 (03) :183-190
[3]   Cellular ions in NIDDM: Relation of calcium to hyperglycemia and cardiac mass [J].
Barbagallo, M ;
Gupta, RK ;
Resnick, LM .
DIABETES CARE, 1996, 19 (12) :1393-1398
[4]   DIABETIC CARDIOMYOPATHY - A UNIQUE ENTITY OR A COMPLICATION OF CORONARY-ARTERY DISEASE [J].
BELL, DSH .
DIABETES CARE, 1995, 18 (05) :708-714
[5]   Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus [J].
Bereket, A ;
Lang, CH ;
Wilson, TA .
HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) :172-181
[6]  
BOUCHARD A, 1989, AM J MED, V87, P160
[7]   Blood pressure-independent cardiac hypertrophy in acromegalic patients [J].
Ciulla, M ;
Arosio, M ;
Barelli, MV ;
Paliotti, R ;
Porretti, S ;
Valentini, P ;
Tortora, G ;
Buonamici, V ;
Moraschi, A ;
Cappiello, V ;
Magrini, F .
JOURNAL OF HYPERTENSION, 1999, 17 (12) :1965-1969
[8]   CLINICAL AND MORPHOLOGICAL FEATURES OF HUMAN HYPERTENSIVE-DIABETIC CARDIOMYOPATHY [J].
FACTOR, SM ;
MINASE, T ;
SONNENBLICK, EH .
AMERICAN HEART JOURNAL, 1980, 99 (04) :446-458
[9]  
FEIN FS, 1991, CARDIOVASC DRUG THER, V48, P65
[10]   Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus [J].
Felicio, JS ;
Ferreira, SRG ;
Plavnik, FL ;
Moisés, V ;
Kohlmann, O ;
Ribeiro, AB ;
Zannella, MT .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (11) :1149-1154